vs
Side-by-side financial comparison of enCore Energy Corp. (EU) and Gossamer Bio, Inc. (GOSS). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $12.4M, roughly 1.1× enCore Energy Corp.). enCore Energy Corp. runs the higher net margin — -173.9% vs -342.3%, a 168.4% gap on every dollar of revenue.
Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
EU vs GOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $13.8M |
| Net Profit | $-21.5M | $-47.2M |
| Gross Margin | 37.9% | — |
| Operating Margin | -135.9% | -333.6% |
| Net Margin | -173.9% | -342.3% |
| Revenue YoY | — | 47.1% |
| Net Profit YoY | — | -43.0% |
| EPS (diluted) | $-0.11 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.4M | $13.8M | ||
| Q3 25 | $8.9M | $13.3M | ||
| Q2 25 | $3.7M | — | ||
| Q1 25 | $18.2M | — | ||
| Q2 24 | — | $95.8M | ||
| Q1 24 | — | $0 | ||
| Q3 23 | — | $0 | ||
| Q2 23 | — | $0 |
| Q4 25 | $-21.5M | $-47.2M | ||
| Q3 25 | $-4.8M | $-48.2M | ||
| Q2 25 | $-6.3M | — | ||
| Q1 25 | $-24.2M | — | ||
| Q2 24 | — | $49.2M | ||
| Q1 24 | — | $-41.9M | ||
| Q3 23 | — | $-40.0M | ||
| Q2 23 | — | $-42.5M |
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | -135.9% | -333.6% | ||
| Q3 25 | -158.2% | -369.4% | ||
| Q2 25 | -526.1% | — | ||
| Q1 25 | -85.7% | — | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | -173.9% | -342.3% | ||
| Q3 25 | -53.7% | -362.7% | ||
| Q2 25 | -172.7% | — | ||
| Q1 25 | -132.9% | — | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | $-0.11 | $-0.21 | ||
| Q3 25 | $-0.03 | $-0.21 | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.13 | — | ||
| Q2 24 | — | $0.22 | ||
| Q1 24 | — | $-0.19 | ||
| Q3 23 | — | $-0.21 | ||
| Q2 23 | — | $-0.45 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | $136.9M |
| Total DebtLower is stronger | $110.0M | — |
| Stockholders' EquityBook value | $229.2M | $-122.8M |
| Total Assets | $430.4M | $172.2M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | $136.9M | ||
| Q3 25 | $91.9M | $180.2M | ||
| Q2 25 | $26.9M | — | ||
| Q1 25 | $29.7M | — | ||
| Q2 24 | — | $354.5M | ||
| Q1 24 | — | $244.4M | ||
| Q3 23 | — | $328.9M | ||
| Q2 23 | — | $162.1M |
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | $229.2M | $-122.8M | ||
| Q3 25 | $248.6M | $-82.3M | ||
| Q2 25 | $264.7M | — | ||
| Q1 25 | $267.9M | — | ||
| Q2 24 | — | $81.5M | ||
| Q1 24 | — | $26.7M | ||
| Q3 23 | — | $104.6M | ||
| Q2 23 | — | $-62.8M |
| Q4 25 | $430.4M | $172.2M | ||
| Q3 25 | $441.9M | $208.8M | ||
| Q2 25 | $359.4M | — | ||
| Q1 25 | $362.6M | — | ||
| Q2 24 | — | $373.4M | ||
| Q1 24 | — | $259.4M | ||
| Q3 23 | — | $347.9M | ||
| Q2 23 | — | $181.7M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.9M | $-48.3M |
| Free Cash FlowOCF − Capex | $7.2M | — |
| FCF MarginFCF / Revenue | 57.8% | — |
| Capex IntensityCapex / Revenue | 46.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.9M | $-48.3M | ||
| Q3 25 | $-20.3M | $-36.2M | ||
| Q2 25 | $-9.9M | — | ||
| Q1 25 | $-7.7M | — | ||
| Q2 24 | — | $116.3M | ||
| Q1 24 | — | $-52.3M | ||
| Q3 23 | — | $-34.5M | ||
| Q2 23 | — | $-38.3M |
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | — | ||
| Q2 25 | $-14.1M | — | ||
| Q1 25 | $-11.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | — | ||
| Q2 25 | -385.2% | — | ||
| Q1 25 | -64.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | 46.7% | 0.0% | ||
| Q3 25 | 68.0% | 0.0% | ||
| Q2 25 | 115.1% | — | ||
| Q1 25 | 21.7% | — | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 2.36× | ||
| Q1 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
